NALOXONE HYDROCHLORIDE INJECTION USP
Google image searchProduct monograph
Active ingredient
naloxone hydrochloride (naloxone hydrochloride dihydrate), 0.4 MG/ML
DIN: 02382482
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 29-APR-2024
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AB — Antidotes (ATC, ATC/DDD)
- V03AB15 — NALOXONE (ATC/DDD)
Reference brand drug: Narcan
Pharmaceutical standard: USP
